Key facts
- Notable investors include Tianjin Binhai Industrial Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhennuo Pharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhennuo Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhennuo Pharmaceuticals
Manufacturer of active pharmaceutical ingredients designed to support drug discovery and therapeutic development. The company offers high-purity antiviral intermediates and fluorinated fine chemicals, enabling pharmaceutical developers and healthcare providers to access reliable raw materials for effective drug manufacturing
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Zhennuo Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhennuo Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhennuo Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.